Industrial Development of Standardized Fetal Progenitor Cell Therapy for Tendon Regenerative Medicine: Preliminary Safety in Xenogeneic Transplantation.

Laurent A, Abdel-Sayed P, Grognuz A, Scaletta C, Hirt-Burri N, Michetti M, de Buys Roessingh AS, Raffoul W, Kronen P, Nuss K, von Rechenberg B, Applegate LA, Darwiche SE

Open source

DOI: 10.3390/biomedicines9040380
Published: 2021 Apr 3
Container: Biomedicines
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3390/biomedicines9040380,
  title = {Industrial Development of Standardized Fetal Progenitor Cell Therapy for Tendon Regenerative Medicine: Preliminary Safety in Xenogeneic Transplantation.},
  author = {Laurent A and Abdel-Sayed P and Grognuz A and Scaletta C and Hirt-Burri N and Michetti M and de Buys Roessingh AS and Raffoul W and Kronen P and Nuss K and von Rechenberg B and Applegate LA and Darwiche SE},
  year = {2021},
  journal = {Biomedicines},
  doi = {10.3390/biomedicines9040380},
  url = {https://doi.org/10.3390/biomedicines9040380}
}

RIS

TY  - JOUR
TI  - Industrial Development of Standardized Fetal Progenitor Cell Therapy for Tendon Regenerative Medicine: Preliminary Safety in Xenogeneic Transplantation.
AU  - Laurent A
AU  - Abdel-Sayed P
AU  - Grognuz A
AU  - Scaletta C
AU  - Hirt-Burri N
AU  - Michetti M
AU  - de Buys Roessingh AS
AU  - Raffoul W
AU  - Kronen P
AU  - Nuss K
AU  - von Rechenberg B
AU  - Applegate LA
AU  - Darwiche SE
PY  - 2021
JO  - Biomedicines
DO  - 10.3390/biomedicines9040380
UR  - https://doi.org/10.3390/biomedicines9040380
ER  -

APA

A, L., P, A., A, G., C, S., N, H., M, M., AS, D. B. R., W, R., P, K., K, N., B, V. R., LA, A., & SE, D. (2021). Industrial Development of Standardized Fetal Progenitor Cell Therapy for Tendon Regenerative Medicine: Preliminary Safety in Xenogeneic Transplantation.. Biomedicines. https://doi.org/10.3390/biomedicines9040380

Source records

pubmed · retrieved 2026-09-26T09:47:42.387Z